510(k) K163357
K163357 is an FDA 510(k) premarket notification submitted by Lifescan Europe, A Division Of Cilag GmbH for the device "OneTouch Via On-Demand Insulin Delivery System". The FDA issued a decision of Substantially Equivalent on Jun 7, 2017. The device falls under product code OPP (Pump, Infusion, Insulin Bolus), a Class II device regulated under 21 CFR 880.5725.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jun 7, 2017
- Date Received
- Nov 30, 2016
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Pump, Infusion, Insulin Bolus
- Device Class
- Class II
- Regulation Number
- 880.5725
- Review Panel
- CH
- Submission Type
The device is adhered to the body for several days for the purpose of periodically infusing an insulin bolus.